Look, I appreciate your perspective, but let’s get real: I’m not...

Look, I appreciate your perspective, but let’s get real: I’m not just adding hype, my view is rooted in the latest data and strategic shifts.

Yes, AHF’s historical results have fallen short of expectations with the previous management, but that’s precisely why the current pivot is so significant.

The half-year report’s lack of promotion on the ‘Future’ launch isn’t a failure; it’s a sign the market hasn’t yet grasped the massive opportunity in the $24 billion Chinese infant formula space.

Insiders are still buying, and with the launch hitting Chinese customers this quarter, the fundamentals suggest a major breakout is imminent. While you dismiss my analysis as hype, the data shows we’re building a leaner, more efficient operation poised for growth.

So those selling now may well be missing the forest for the trees.